Julie A. Barta MD

Dr. Julie Barta is Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Thomas Jefferson University in Philadelphia and Lead for the Korman Respiratory Institute’s Lung Cancer, Screening, and Nodules Program at Jefferson. Upon joining the Pulmonary and Critical Care Medicine faculty at Jefferson in 2015, Dr. Barta’s translational research focused on elucidating the gain-of-function role of mutant p53 in lung carcinogenesis, supported by a grant from the American Cancer Society.

In her clinical role, Dr. Barta has developed centralized Lung Cancer Screening (LCS) and Lung Nodule Programs across the 18-hospital Jefferson Health Enterprise. She has expanded the LCS mission to include population science research collaborations and community outreach tailored to underserved groups in Philadelphia, and she has served as PI for multiple industry-sponsored and investigator-initiated clinical trials in the LCS and Lung Nodule Programs at Jefferson.

Dr. Barta has a committed research focus on the early detection of lung cancer. She received an Outstanding Young Investigator Award in 2021 from the Prevent Cancer Foundation, as well as additional research funding from industry and from the Pennsylvania Department of Health. Dr. Barta’s recent publications and current projects focus on defining lung cancer risk, improving LCS uptake and adherence, and investigating diagnostic strategies for early detection. Dr. Barta is also active at the national level, serving in leadership roles for the American Thoracic Society and the ACS National Lung Cancer Roundtable.